Pneumococcal Disease
A group of illnesses caused by Streptococcus pneumoniae bacteria, including ear and sinus infections, pneumonia, bloodstream infection, and meningitis.
What causes Pneumococcal Disease?
Pneumococcal disease is caused by Streptococcus pneumoniae. Bacteria spread through respiratory secretions and may colonize the nose or throat without symptoms before invading the lungs, blood, or tissues around the brain.
Symptoms and what to notice
Symptoms depend on the site: fever, cough, chest pain, rapid or difficult breathing with pneumonia; headache, stiff neck, confusion, or light sensitivity with meningitis; or fever, chills, and weakness with bloodstream infection.
How long can it last?
Incubation can be short, and invasive disease may worsen rapidly. Uncomplicated infections often improve within days after effective treatment, while pneumonia, meningitis, or sepsis may require weeks of recovery.
How serious is Pneumococcal Disease?
Pneumococcal pneumonia, bacteremia, and meningitis can cause respiratory failure, shock, hearing loss, neurologic injury, limb damage, or death. Young children, older adults, and people with certain chronic or immune conditions face greater risk.
Treatment and management
Antibiotics are selected according to infection site, severity, local resistance, test results, allergies, and patient factors. Severe disease requires hospital care and may need intravenous antibiotics, oxygen, fluids, or intensive support.
Vaccine: who and when?
U.S. products are Vaxneuvance (PCV15), Prevnar 20 (PCV20), CAPVAXIVE (PCV21), and Pneumovax 23 (PPSV23). Children routinely receive age-appropriate PCV doses. Adults age 50 or older and younger people with qualifying risks follow CDC schedules; PCV15 is followed by PPSV23, while PCV20 or PCV21 can complete vaccination in many adults.
Cost note: Patient cost varies by product, provider, insurance, location, and eligibility. Many recommended vaccines are covered in network without cost sharing, and qualifying children may use the Vaccines for Children program.
Trusted source
Patient cost varies by insurance, provider, location, and eligibility. Coverage and public-health access differ, so listed prices are examples rather than guaranteed patient prices. This page is for general education and does not replace individualized medical advice, diagnosis, vaccination assessment, or treatment.
Pneumococcal Disease: Symptoms, Causes, Treatment, Prevention, and Vaccine Information
Pneumococcus commonly lives in the upper respiratory tract but can cause illnesses ranging from mild ear infection to life-threatening meningitis and sepsis. More than one hundred serotypes exist, so vaccines target types responsible for a large share of severe disease. Product choice now depends on age, risk factors, and previous pneumococcal vaccines.
Important: This page is for general education. It does not replace diagnosis, treatment, vaccination advice, or emergency care from a qualified healthcare professional.
Quick Facts
| Topic | Current information |
|---|---|
| Cause | Pneumococcal disease is caused by Streptococcus pneumoniae. Bacteria spread through respiratory secretions and may colonize the nose or throat without symptoms before invading the lungs, blood, or tissues around the brain. |
| Main symptoms | Symptoms depend on the site: fever, cough, chest pain, rapid or difficult breathing with pneumonia; headache, stiff neck, confusion, or light sensitivity with meningitis; or fever, chills, and weakness with bloodstream infection. |
| Typical course | Incubation can be short, and invasive disease may worsen rapidly. Uncomplicated infections often improve within days after effective treatment, while pneumonia, meningitis, or sepsis may require weeks of recovery. |
| Treatment | Antibiotics are selected according to infection site, severity, local resistance, test results, allergies, and patient factors. Severe disease requires hospital care and may need intravenous antibiotics, oxygen, fluids, or intensive support. |
| Vaccine status | U.S. products are Vaxneuvance (PCV15), Prevnar 20 (PCV20), CAPVAXIVE (PCV21), and Pneumovax 23 (PPSV23). Children routinely receive age-appropriate PCV doses. Adults age 50 or older and younger people with qualifying risks follow CDC schedules; PCV15 is followed by PPSV23, while PCV20 or PCV21 can complete vaccination in many adults. |
History and Public-Health Importance
Pneumococcal polysaccharide vaccine was followed by conjugate vaccines that generate stronger immune memory and protect young children. Childhood vaccination dramatically reduced invasive disease caused by covered serotypes and also lowered transmission. Newer PCV15, PCV20, and PCV21 products broaden coverage, while surveillance watches for disease caused by serotypes not included in vaccines.
What Causes Pneumococcal Disease?
Pneumococcal disease is caused by Streptococcus pneumoniae. Bacteria spread through respiratory secretions and may colonize the nose or throat without symptoms before invading the lungs, blood, or tissues around the brain.
Respiratory droplets and direct contact with secretions spread pneumococci. Many healthy people, especially children, carry bacteria without symptoms. Viral respiratory infection, smoking, older age, lack of a functioning spleen, cochlear implants, cerebrospinal-fluid leaks, and chronic heart, lung, kidney, liver, or immune disease can increase invasive risk.
Symptoms and Typical Course
Symptoms depend on the site: fever, cough, chest pain, rapid or difficult breathing with pneumonia; headache, stiff neck, confusion, or light sensitivity with meningitis; or fever, chills, and weakness with bloodstream infection.
Ear and sinus infections may be localized, while pneumonia often causes abrupt fever, chills, cough, chest pain, and shortness of breath. Older adults may present mainly with weakness or confusion. Meningitis can produce stiff neck, severe headache, vomiting, light sensitivity, or reduced consciousness. Bloodstream infection can rapidly progress to sepsis.
Complications and Who Is at Higher Risk
Pneumococcal pneumonia, bacteremia, and meningitis can cause respiratory failure, shock, hearing loss, neurologic injury, limb damage, or death. Young children, older adults, and people with certain chronic or immune conditions face greater risk.
Pneumonia can cause respiratory failure, empyema, or infection around the heart. Meningitis may leave hearing loss, seizures, cognitive impairment, or motor disability. Bacteremia can seed joints, bones, heart valves, or other organs. Asplenia and complement or immune disorders greatly increase risk.
How It Is Diagnosed
Clinicians use examination, chest imaging, blood tests, blood culture, sputum studies, or cerebrospinal-fluid testing depending on the syndrome. Culture and molecular tests help identify pneumococcus, while susceptibility testing guides antibiotics. Treatment begins promptly when invasive disease is suspected.
Treatment and Recovery
Antibiotics are selected according to infection site, severity, local resistance, test results, allergies, and patient factors. Severe disease requires hospital care and may need intravenous antibiotics, oxygen, fluids, or intensive support.
Antibiotic choices differ for outpatient pneumonia, hospitalized pneumonia, meningitis, and resistant infection. Ceftriaxone, cefotaxime, penicillin-family drugs, macrolides, fluoroquinolones, or vancomycin may be considered in appropriate combinations, but self-treatment is unsafe. Clinicians narrow therapy after cultures and susceptibility results.
Vaccine Information
U.S. products are Vaxneuvance (PCV15), Prevnar 20 (PCV20), CAPVAXIVE (PCV21), and Pneumovax 23 (PPSV23). Children routinely receive age-appropriate PCV doses. Adults age 50 or older and younger people with qualifying risks follow CDC schedules; PCV15 is followed by PPSV23, while PCV20 or PCV21 can complete vaccination in many adults.
Vaxneuvance covers 15 serotypes, Prevnar 20 covers 20, CAPVAXIVE covers 21, and Pneumovax 23 is a 23-valent polysaccharide vaccine. Pediatric schedules use PCV15 or PCV20. Adult schedules depend on prior products and may use PCV20 or PCV21 alone, or PCV15 followed by PPSV23. Some immunocompromised patients and children with risk conditions need specialized timing.
Prevention
Receive the recommended pneumococcal series, keep influenza and other vaccines current, avoid smoking, wash hands, and manage chronic diseases. Vaccination reduces severe disease but does not prevent every pneumonia or every pneumococcal serotype.
When to Seek Medical Care
Seek urgent care for difficulty breathing, chest pain, blue lips, confusion, stiff neck, severe headache, a nonresponsive child, or rapidly worsening fever. Older adults may need evaluation for new confusion or sudden weakness even without classic symptoms.
Frequently Asked Questions
Is pneumococcal disease one illness?
No. The same bacteria can cause ear infection, sinusitis, pneumonia, bacteremia, meningitis, and other invasive infections.
Which vaccine should an adult receive?
It depends on age, health risks, and previous vaccines. CDC schedules commonly use PCV20 or PCV21 alone, or PCV15 followed by PPSV23.
Can vaccination prevent every pneumonia?
No. Many pathogens cause pneumonia, and vaccines cover selected pneumococcal serotypes, but they substantially reduce severe covered disease.
Are antibiotics always the same?
No. Site, severity, resistance, allergies, and laboratory results determine treatment.
Key Takeaway
Pneumococcal disease ranges from common localized infection to sudden meningitis and sepsis. Prompt antibiotics for invasive illness and correct age- and risk-based vaccination save lives.
Medical, treatment, and vaccine information was reviewed against official U.S. public-health guidance available through September 2026.